These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1929 related items for PubMed ID: 26242406

  • 1. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H, Peng X, Jiao H, Zhao D, Ouyang J.
    Microb Cell Fact; 2015 Aug 05; 14():111. PubMed ID: 26242406
    [Abstract] [Full Text] [Related]

  • 2. Cross-protection of Lactococcus lactis-displayed HA2 subunit against homologous and heterologous influenza A viruses in mice.
    Lei H, Peng X, Zhao D, Jiao H, Ouyang J.
    Arch Virol; 2015 Dec 05; 160(12):3011-9. PubMed ID: 26358264
    [Abstract] [Full Text] [Related]

  • 3. Cross-protective immunity of the haemagglutinin stalk domain presented on the surface of Lactococcus lactis against divergent influenza viruses in mice.
    Lei H, Gao T, Cen Q.
    Virulence; 2021 Dec 05; 12(1):12-19. PubMed ID: 33372841
    [Abstract] [Full Text] [Related]

  • 4. Lactococcus lactis displayed neuraminidase confers cross protective immunity against influenza A viruses in mice.
    Lei H, Peng X, Zhao D, Ouyang J, Jiao H, Shu H, Ge X.
    Virology; 2015 Feb 05; 476():189-195. PubMed ID: 25546254
    [Abstract] [Full Text] [Related]

  • 5. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 6. Mucosally administered Lactobacillus surface-displayed influenza antigens (sM2 and HA2) with cholera toxin subunit A1 (CTA1) Induce broadly protective immune responses against divergent influenza subtypes.
    Li R, Chowdhury MY, Kim JH, Kim TH, Pathinayake P, Koo WS, Park ME, Yoon JE, Roh JB, Hong SP, Sung MH, Lee JS, Kim CJ.
    Vet Microbiol; 2015 Sep 30; 179(3-4):250-63. PubMed ID: 26210951
    [Abstract] [Full Text] [Related]

  • 7. Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines.
    Thueng-in K, Maneewatch S, Srimanote P, Songserm T, Tapchaisri P, Sookrung N, Tongtawe P, Channarong S, Chaicumpa W.
    Vaccine; 2010 Sep 24; 28(41):6765-77. PubMed ID: 20688037
    [Abstract] [Full Text] [Related]

  • 8. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M, Tao P, Li J, Zhou S, Guo D, Pan Z.
    J Virol Methods; 2008 Dec 24; 154(1-2):121-7. PubMed ID: 18789973
    [Abstract] [Full Text] [Related]

  • 9. Intranasal immunization of recombinant Lactococcus lactis induces protection against H5N1 virus in ferrets.
    Lei H, Peng X, Ouyang J, Zhao D, Jiao H, Shu H, Ge X.
    Virus Res; 2015 Jan 22; 196():56-9. PubMed ID: 25445345
    [Abstract] [Full Text] [Related]

  • 10. Protective immunity against influenza H5N1 virus challenge in chickens by oral administration of recombinant Lactococcus lactis expressing neuraminidase.
    Lei H, Peng X, Ouyang J, Zhao D, Jiao H, Shu H, Ge X.
    BMC Vet Res; 2015 Apr 02; 11():85. PubMed ID: 25880824
    [Abstract] [Full Text] [Related]

  • 11. Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant.
    Zheng M, Liu F, Shen Y, Wang S, Xu W, Fang F, Sun B, Xie Z, Chen Z.
    Hum Vaccin Immunother; 2015 Apr 02; 11(2):397-406. PubMed ID: 25607884
    [Abstract] [Full Text] [Related]

  • 12. Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses.
    Li Z, Gabbard JD, Mooney A, Gao X, Chen Z, Place RJ, Tompkins SM, He B.
    J Virol; 2013 May 02; 87(10):5985-93. PubMed ID: 23514880
    [Abstract] [Full Text] [Related]

  • 13. The virus-induced signaling adaptor molecule enhances DNA-raised immune protection against H5N1 influenza virus infection in mice.
    Luo M, Qu X, Pan R, Zhu D, Zhang Y, Wu J, Pan Z.
    Vaccine; 2011 Mar 21; 29(14):2561-7. PubMed ID: 21303708
    [Abstract] [Full Text] [Related]

  • 14. Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice.
    Wang W, Li R, Deng Y, Lu N, Chen H, Meng X, Wang W, Wang X, Yan K, Qi X, Zhang X, Xin W, Lu Z, Li X, Bian T, Gao Y, Tan W, Ruan L.
    Clin Vaccine Immunol; 2015 Jun 21; 22(6):618-30. PubMed ID: 25834017
    [Abstract] [Full Text] [Related]

  • 15. Influenza Chimeric Protein (3M2e-3HA2-NP) Adjuvanted with PGA/Alum Confers Cross-Protection against Heterologous Influenza A Viruses.
    Kwak C, Nguyen QT, Kim J, Kim TH, Poo H.
    J Microbiol Biotechnol; 2021 Feb 28; 31(2):304-316. PubMed ID: 33263336
    [Abstract] [Full Text] [Related]

  • 16. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC, Lin CY, Tsou YT, Jan JT, Wu SC.
    J Virol; 2015 Jul 28; 89(14):7224-34. PubMed ID: 25948745
    [Abstract] [Full Text] [Related]

  • 17. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A, Haijema BJ, Voorn P, Meijerhof T, van Roosmalen ML, Leenhouts K.
    Vaccine; 2012 Jul 06; 30(32):4884-91. PubMed ID: 22537989
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of oral immunization with recombinant avian influenza virus HA1 displayed on the Lactococcus lactis surface and combined with the mucosal adjuvant cholera toxin subunit B.
    Lei H, Sheng Z, Ding Q, Chen J, Wei X, Lam DM, Xu Y.
    Clin Vaccine Immunol; 2011 Jul 06; 18(7):1046-51. PubMed ID: 21632890
    [Abstract] [Full Text] [Related]

  • 19. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD, Gitelman AK, Smirnov YA, Piskareva LM, Zakharova LG, Pashvykina GV, Shmarov MM, Zhirnov OP, Varich NP, Ilyinskii PO, Shneider AM.
    Arch Virol; 2006 May 06; 151(5):921-31. PubMed ID: 16292596
    [Abstract] [Full Text] [Related]

  • 20. Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.
    Xue C, Tian G, Chen X, Liu Q, Ma J, Xu S, Li X, Chen H, Cao Y.
    Virus Res; 2015 Jan 02; 195():35-42. PubMed ID: 25312452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 97.